Raaj Medisafe India Share Price
Small Cap | Plastics | BSE: 524502
₹73.50 0.05 (0.07 %)
Last Updated: 25 Feb 2025 12:00 AM
Overview
Open (₹) 69.80
High (₹) 73.50
Low (₹) 69.80
Prev. Close (₹) 73.45
Volume 300
VWAP (₹) 71.03
ROCE (%) 23.04
Industry P/E 35.72
TTM P/E 28.94
P/B Ratio 7.39
Market Cap (₹) Cr.97.11
Dividend Yield (%)--
EPS (₹) 3.07
ROE30.89%
Sales Growth (%) 11.98
Profit Growth (%)-0.04
Day Range
73.5073.50
52 Week Range
46.20122.60
Historical Returns
Returns (6M)
-22.63 %
Returns (1Y)
36.54 %
Returns (3Y)
140.59 %
Returns (5Y)
699.78 %
Returns (6M)
-22.63 %
Returns (1Y)
36.54 %
Returns (3Y)
140.59 %
Returns (5Y)
699.78 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 47.04
MFI 38.99
ATR 3.51
Commodity Channel Index 67.27
ROC125 3.52
ROC21 -8.12
Williams %R -3.50
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 74.74 | 75.97 | 78.44 | 72.27 | 71.04 | 68.57 | 67.34 |
Week Ago | 70.20 | 70.20 | 70.20 | 70.20 | 70.20 | 70.20 | 70.20 |
Month Ago | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 | 67.00 |
EMA & SMA
73.50
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
7
5 Day 70.58
9 Day 68.72
10 Day 69.11
12 Day 68.41
14 Day 68.66
20 Day 70.77
26 Day 73.69
50 Day 79.88
100 Day 91.12
200 Day 78.15
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
HIMASHU SHARMA | bulk | Sell | 29 Mar, 2023 | ₹24.58 | 60,000 | BSE |
BETARSTEP TRADING PVT LTD | bulk | Sell | 01 Oct, 2021 | ₹59.75 | 62,100 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
10 May, 2024 | Vishnu Jajoo | Acquisition | ₹44.00 | 3,34,000 | BSE |
10 May, 2024 | Samiksha Bangur | Acquisition | ₹44.00 | 3,34,000 | BSE |
10 May, 2024 | Arpit Bangur | Acquisition | ₹44.00 | 3,34,000 | BSE |
10 May, 2024 | Anand Bangur | Acquisition | ₹44.00 | 3,34,000 | BSE |
10 May, 2024 | Mangla Bangur | Acquisition | ₹44.00 | 3,34,000 | BSE |
17 Apr, 2021 | Vishnu Jajoo | Acquisition | ₹ | 4,77,900 | BSE |
17 Apr, 2021 | Anand Bangur | Acquisition | ₹ | 11,50,028 | BSE |
17 Apr, 2021 | Sushen Remedies Pvt. Ltd. | Acquisition | ₹ | 2,68,627 | BSE |
17 Apr, 2021 | Arpit Packaging Pvt.Ltd. | Acquisition | ₹ | 4,95,600 | BSE |
17 Apr, 2021 | Vyanktesh Securities IMF Pvt. Ltd. | Acquisition | ₹ | 5,60,500 | BSE |
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
11 Feb, 2025 | BSE India | We attach herewith Integrated (Financial) Report for the quarter ended December 31, 2024 which has been reviewed by the Audit Committee and taken on record by the Board of Directors in its meeting held on 11/02/2025 |
11 Feb, 2025 | BSE India | We attach herewith unaudited financial results of the for the quarter ended December 31, 2024 which were reviewed to Audit Committee and taken on record by the Board of Directors of the Company in its meeting held on 11/02/025. |
11 Feb, 2025 | BSE India | The Board of Directors in its meeting held on today i.e. 11/02/2025, inter-alia, has approved and taken on record the Unaudited Financial Results for the quarter ended December 31, 2024 and also approved/taken on record other items of Business as per letter attached. |
03 Feb, 2025 | BSE India | RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 ,inter alia, to consider and approve We would like to inform you that next meeting of the Board of Directors is scheduled to be held on Tuesday, the 11th day of February, 2025 at 3.00 PM at the Registered Office at 75/2 & 3, Industrial Area, Maksi Road, Ujjain-456010 inter-alia to consider and to take on record Unaudited Financial Results of the Company for the Quarter ended December 31, 2024 and other items of business as per letter attached herewith. |
04 Jan, 2025 | BSE India | We submit herewith Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2024 as received from RTA Ankit Consultancy Pvt Ltd. |
14 Nov, 2024 | BSE India | We enclosed herewith statement of Funds raised through Preferential Issue and utilization of Fund raised. |
12 Nov, 2024 | BSE India | Attached herewith please find the Unaudited Financial Results of the Company for the Quarter ended September 30, 2024, Statement of Assets and Liabilities-30.09.2024, Cash Flow Statement for the half year ended September 30.2024 and Limited review Report issued by the Statutory Auditors of the Company.\r\nThe aforesaid results and other statements have been reviewed by the Audit Committee and taken on records by the Board in it meeting held on November 12, 2024 |
12 Nov, 2024 | BSE India | The Board of Directors has approved and taken on records the Unaudited Financial Results for the quarter ended September 30, 2024 and other statements related thereto.\r\nThe Board of Directors has also approved/taken on record the other items as per letter attached |
05 Nov, 2024 | BSE India | RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Board Meeting is convened on 12.11.2024 inter-alia to take on record Unaudited Financial Results of the Company for the quarter ended September 30, 2024 and other reports/statements and other items as per Agenda attached. |
09 Oct, 2024 | BSE India | We attach herewith compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2024 as received from RTA Ankit Consultancy Pvt. Ltd. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 04 Feb, 2025 | 11 Feb, 2025 |
Quarterly Results | -- | 06 Nov, 2024 | 12 Nov, 2024 |
Quarterly Results | -- | 15 Aug, 2024 | 14 Aug, 2024 |
Audited Results | -- | 23 May, 2024 | 29 May, 2024 |
Preferential issue of shares | -- | 04 May, 2024 | 06 May, 2024 |
Quarterly Results | -- | 01 Feb, 2024 | 09 Feb, 2024 |
Others | To consider and approve expansion of existing manufacturing capacities of the Company as per letter attached. | 09 Jan, 2024 | 16 Jan, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 08 Nov, 2023 |
Quarterly Results & A.G.M. | -- | 02 Aug, 2023 | 08 Aug, 2023 |
Audited Results | -- | 24 May, 2023 | 29 May, 2023 |
Share Holding Pattern
Owner Name | Sept, 2024 | Aug, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
---|
About Raaj Medisafe India
Raaj Medisafe India is a Public Limited Listed company incorporated on 12/09/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L33112MP1985PLC003039 and registration number is 003039. Currently Company is involved in the business activities of Manufacture of plastic articles for the packing of goods (plastic bags, sacks, containers, boxes, cases, carboys, bottles etc.). Company’s Total Operating Revenue is Rs. 43.25 Cr. and Equity Capital is Rs. 10.90 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1985
Managing Director
Mr. Arpit Bangur
NSE Symbol
--
Raaj Medisafe India Management
Name | Designation |
---|---|
Mr. Arpit Bangur | Managing Director |
Mr. Navin Jhawar | Joint Managing Director |
Mr. Krishna Jajoo | Non Executive Director |
Mr. Rakesh Agrawal | Ind. Non-Executive Director |
Mr. Rajesh Kumar Gupta | Ind. Non-Executive Director |
Mr. Vijendra Kumar Sood | Ind. Non-Executive Director |
Mr. Hemant Kasliwal | Additional Director |
Mr. Ateet Agrawal | Additional Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Supreme Inds | ₹60,685.18 | ₹3,575.95 ₹3,694.35(-3.20%) | ₹3,604.200 - ₹6,482.400 |
Anmol Trdng | ₹6,729.22 | ₹1,518.20 ₹1,479.50(2.62%) | ₹312.100 - ₹1,538.300 |
HydroS&SInds | ₹4,148.01 | ₹2,919.30 ₹2,910.40(0.31%) | ₹1,400.000 - ₹3,717.000 |
Ddev Plastik | ₹2,849.33 | ₹243.05 ₹253.45(-4.10%) | ₹160.000 - ₹458.500 |
NilkamalPlst | ₹2,842.82 | ₹1,621.70 ₹1,612.10(0.60%) | ₹1,630.000 - ₹2,355.000 |
FAQs on Raaj Medisafe India
What is the share price of Raaj Medisafe India?
The share price of Raaj Medisafe India on 25 Feb, 2025 is ₹ 73.50.
What is 52W high and 52W low share price of Raaj Medisafe India?
The highest and lowest 52W share prices of Raaj Medisafe India are ₹ 122.600 and ₹ 38.210
What is the market cap of Raaj Medisafe India?
The market capitalization of Raaj Medisafe India as of 25 Feb, 2025 is ₹ 97.11 Crores
What is the P/E ratio of Raaj Medisafe India?
The current P/E ratio of Raaj Medisafe India as of 25 Feb, 2025 is 35.72
What is the PB ratio of Raaj Medisafe India?
The PB ratio of Raaj Medisafe India as of 25 Feb, 2025 is 7.39
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)